Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5003615 | 1.00 | ESR1 (0.33) | ESR1ESR2ACHE | |
| SCHEMBL333101 | 0.82 | ESR1 (0.31) | ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL7337175 | 0.81 | ACHE (0.32) | ESR1ESR2ACHE | |
| SCHEMBL8973657 | 0.81 | ESR1 (0.30) | ESR1ESR2 | |
| SCHEMBL27203887 | 0.76 | ESR1 (0.34) | ESR1ESR2ACHE | |
| SCHEMBL10258004 | 0.76 | CHRNB2 (0.41) | ESR1ESR2ACHE | |
| SCHEMBL10257201 | 0.76 | CHRNB2 (0.41) | ESR1ESR2ACHE | |
| SCHEMBL31136551 | 0.76 | ESR1 (0.34) | ESR1ESR2ACHE | |
| SCHEMBL1858912 | 0.76 | CHRNB2 (0.41) | ESR1ESR2ACHE | |
| SCHEMBL26518 | 0.72 | ACHE (0.36) | ESR1ESR2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |